I'm Joe Gradyton and I'm Terry Grady. Welcome to this podcast of the People's Pharmacy.

You can find previous podcasts and more information on a range of health topics at people's pharmacy.com.

Immune modulating drugs to treat severe

autoimmune conditions are some of the priciest drugs in the pharmacy.

This is the People's Pharmacy with Terry and

Joe Grayden. A recent study shows that these biologic agents have an unexpected downside.

They can trigger other autoimmune diseases such as psoriatic arthritis or

hydratonitis superotiva. Drugs like Humira or Enbrel can cost between

eight and 12,000 dollars a month. Even with good insurance the co-pays can be daunting.

Stopping these drugs requires medical supervision. So do common assets oppressing

medications like Proisec or Nexium.

Coming up on the People's Pharmacy, the pros and cons of immune modifying drugs.

In the People's Pharmacy Health Headlines, People who have caught COVID-19 may be at increased risk

for cardiovascular complications in the future.

That's the conclusion of a small autopsy study of patients who had contracted SARS-Covi too.

Most cardiologists blame heart disease on lipid factors such as elevated

LDL cholesterol, but there has been evidence that infections can trigger coronary artery disease leading to heart attacks.

While most people associate the long-term consequences of COVID

with shortness of breath, brain fog, or fatigue,

the new study suggests that the virus causes blood vessel

inflammation and leads to the development of arterial plaque. The researchers found that the virus homes in on foam cells that infiltrate

arterial walls. The patients in the study already had cardiovascular

...